Hospital Microbiology Testing Market
Number of pages: 100 | Report Format: PDF | Published date: 08 February, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market size value in 2021 |
US$ 2.04 billion |
|
Revenue forecast in 2030 |
US$ 4.84 billion |
|
Growth Rate |
CAGR of 10.1% from 2022 to 2030 |
|
Base year for estimation |
2021 |
|
Forecast period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments covered |
Product type, Application, End user and Region |
|
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The global hospital microbiology testing market was pegged at US$ 2.04 billion in 2021 and is expected to witness a CAGR of 10.1% during the forecast period.
Market Fundamental
Hospital microbiology testing is a type of clinical laboratory testing that involves doing numerous assays and blood draws in hospitals. It facilitates effective management of infectious disease concerns. However, Microbiology is the branch of medicine that deals with the treatment, diagnosis, and eradication of infectious diseases. Rapid microbiological testing aids in increasing product safety profiles, tracking critical control points in real-time, identifying microbial dangers more immediately, improving production processes, and lowering overall quality programme costs. Rapid microbiology testing Applications are also known as microbiological Applications, and these are the types of technologies that help to obtain microbiology test results faster than traditional culture-plate Applications. Furthermore, manufacturers and players in the global hospital microbiology testing market provide a wide range of tests, such as fungal, viral, and bacterial tests, as well as instruments and consumables to their end customers, which include hospitals and clinics. Microscopy, molecular diagnostics, microbial culture, and biochemical assays are some of the primary methods used in the global hospital microbiology testing market.
[57546433]
Market Dynamic
The increasing availability and efficacy of various anti-viral therapy treatments intended at the treatment of illnesses such as gingivitis, COPD or chronic pulmonary obstructive disease, and periodontitis, among others, is propelling the global hospital microbiology testing market forward. Furthermore, the rising prevalence of sexually transmitted illnesses is driving up demand in the global hospital microbiology testing market. As a result, an increase in sex and sexuality awareness in various emerging countries is contributing to market growth. Furthermore, increased investments in microbiology testing solutions and relevant equipment are likely to drive the growth of the worldwide hospital microbiology testing market in the coming years. Additionally, rapid technical advancements are also being observed globally, which are expected to fuel the microbiology testing market in the approaching years. Over the forecast period, emerging economies such as India and China may offer new growth prospects for the hospital microbiological testing market. To grow market share, industry players are employing various methods such as acquisitions, collaborations, partnerships, and expansions. For example, in July 2020, bioMérieux SA developed BIOFIRE MYCOPLASMA, a novel test for mycoplasma identification in pharmaceutical goods used for biotherapeutics (antibodies, hormones, cell and gene treatments, and so on), the pharmaceutical industry's most lively sector. As a result, the rising prevalence of chronic and infectious diseases is likely to fuel the expansion of the microbiology testing market. Furthermore, rising medical expenditures, as well as the existence of well-trained and advanced healthcare infrastructure in both established and developing nations, are driving growth in the global hospital microbiology testing market. However, concerns such as laboratory reimbursement and the high cost of microbiology tools may stifle market expansion soon.
Market Ecosystem
The global hospital microbiology testing market has been analysed from four perspective by product type, application, end user and region.
Hospital Microbiology Testing Market by Product type
[64563453]
Based on product type, the global hospital microbiology testing market include instruments, chemicals and reagents, consumables and accessories, others. The instrument segment dominated the market during forecast period and this trend will continue in the future due to factors such as constant technical improvements in the field of microbiology testing equipment and a focus on laboratory automation.
Hospital Microbiology Testing Market by Application
Based on application, the global hospital microbiology testing market include gastrointestinal infections, respiratory infections, urinary tract infections, sexually transmitted infections, others. The respiratory infections segment dominated the market during forecast period due to the vast number of patients suffering from respiratory diseases, the rising incidence of target respiratory diseases (including tuberculosis, asthma, COPD, and bronchitis) in emerging nations, and the increasing frequency of epidemic outbreaks of respiratory infections.
Hospital Microbiology Testing Market by Region
Based on region, the global hospital microbiology testing market include North America, Europe, Asia Pacific, Rest of the World. North America has the largest share of the global hospital microbiology testing market, owing to the rising prevalence of chronic and acute diseases, the presence of well-established and technologically advanced healthcare infrastructure, and the region's rising demand for technologically advanced and accurate diagnostic testing capabilities. The COVID-19 pandemic in North America underlined the necessity for disease diagnosis and research groups to engage with the government to create new diagnostic techniques in order to meet future health crises. Furthermore, the United States is the world's most COVID-affected country. As a result, the demand for COVID-19 diagnostics is quite strong, which bodes well for market growth. According to a report published in April 2022 by the Centres for Disease Control and Prevention, approximately 677,769 cases of gonorrhoea were documented. In addition, gonorrhoea has emerged as the second most visible sexually transmitted diseases in the United States.
Europe has the second-largest share of the worldwide hospital microbiology testing market, but growing Asian Pacific nations are likely to give attractive growth and expansion prospects in the future years. The growing relevance of medical tourism, new and attractive reimbursement policies, and tax breaks are fuelling the growth of the Asia Pacific hospital microbiology testing market.
Competitive landscape
Some of the prominent market players in the global hospital microbiology testing market include,
Hospital microbiology testing market competition is modest. New product launches, mergers and acquisitions, partnerships, joint ventures, and techniques employed by significant players to obtain a competitive advantage have all occurred in the companies. Companies are also introducing new microbiological automated systems with high throughputs and shorter turnaround times. Additionally, Manufacturers and players in the global hospital microbiology testing market provide a wide range of tests, such as fungal, viral, and bacterial tests, as well as instruments and consumables to their end customers, which include hospitals and clinics. Microscopy, molecular diagnostics, microbial culture, and biochemical assays are some of the primary methods used in the global hospital microbiology testing market.
Strategic Development
The Europe is the key growth region in the global hospital microbiology testing market.
The technological advancements in microbiology testing, rising private-public funding for research on infectious diseases.
Some of the prominent market players in the global hospital microbiology testing market include Thermo Fisher Scientific, Inc., Bio Rad Laboratories, Inc., Siemens Healthcare Diagnostics, Inc., Sysmex Corporation, F. Hoffmann La Roche Ltd., Quidel Corporation, Dickinson, and Company, Biomerieux Inc., Gen-Probe, Inc., and Abbott Laboratories, Inc., Merck KGaA.
The respiratory infection segment accounts for the largest share in the global hospital microbiology testing market
Hospital microbiology testing is a type of clinical laboratory testing that involves doing numerous assays and blood draws in hospitals. It facilitates effective management of infectious disease concerns.
*Insights on financial performance are subject to availability of the information in the public domain
Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.
GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.
Snehal Deshmukh
Principle Consultant
Speak to analyst